Related Experiment Videos
[Blood coagulation, genetics and post-angioplasty restenosis]
M García-Ribes1, D González-Lamuño, T Colman
1Departamento de Ciencias Médicas y Quirúrgicas, Universidad de Cantabria. garciami@medi.unican.es
Insights
Genetic factors influence thrombus formation and restenosis after coronary angioplasty. Understanding these genetic links helps tailor anticoagulant therapy for individual patients with coronary heart disease.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Pharmacology
Context:
- Coronary heart disease is a leading cause of death globally.
- Atherosclerosis and restenosis after revascularization are complex processes.
- Endothelial injury and repair mechanisms are central to atherosclerosis pathogenesis.
Purpose:
- To review genetic factors associated with thrombus formation and restenosis.
- To explore the relationship between genetic variations and anticoagulant therapy response.
- To identify optimal anticoagulant strategies based on individual genetic profiles.
Summary:
- This review examines genetic factors influencing thrombus formation, a key element in restenosis post-percutaneous transluminal coronary angioplasty.
- It discusses genes for platelet receptors, fibrinogen, factor Xa, plasminogen activator inhibitor-1 (PAI-I), and apolipoprotein (a).
- The findings aim to personalize anticoagulant treatment for patients undergoing revascularization procedures.
Impact:
- Personalized medicine approaches in cardiology.
- Improved patient outcomes and reduced restenosis rates.
- Enhanced understanding of the genetic underpinnings of thrombotic disorders.
Abstract:
Throughout the last few decades, different factors have been related to coronary stenosis which is clinically evidenced by coronary heart disease, the leading cause of death in developed countries. Different experimental models have contributed towards defining some of these factors, and to an understanding of the physiopathology of the atherosclerotic lesion. The genetic basis related to individual responses to the same event is currently being established. As endothelial injury reparative mechanisms are fundamental in atherosclerosis pathogeny, patients who experiment restenosis after undergoing revascularization procedures are useful human models in the study of these processes. We review from the literature the genetic factors related to thrombus formation, which may be associated with restenosis after percutaneous transluminal coronary angioplasty, in order to define the most suitable anticoagulant therapy for each patient. We refer to the recently characterized gene for the platelet receptors and its relationship with fibrinogenous, factor Xa, PAI-I, and the involvement of apolipoprotein (a) in the coagulation process.